{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T07:46:35Z","timestamp":1793691995229,"version":"4.5.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T00:00:00Z","timestamp":1716768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T00:00:00Z","timestamp":1716768000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82350108"],"award-info":[{"award-number":["82350108"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1038\/s41590-024-01834-9","type":"journal-article","created":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T12:01:53Z","timestamp":1716811313000},"page":"1059-1072","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["A single infusion of engineered long-lived and multifunctional T cells confers durable remission of asthma in mice"],"prefix":"10.1038","volume":"25","author":[{"given":"Gang","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7991-4013","authenticated-orcid":false,"given":"Lixia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaocui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuying","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1379-8279","authenticated-orcid":false,"given":"Zhuoyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5885-0660","authenticated-orcid":false,"given":"Min","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,27]]},"reference":[{"key":"1834_CR1","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/imr.12132","volume":"257","author":"CS Hinrichs","year":"2014","unstructured":"Hinrichs, C. S. & Rosenberg, S. A. Exploiting the curative potential of adoptive T-cell therapy for cancer. Immunol. Rev. 257, 56\u201371 (2014).","journal-title":"Immunol. Rev."},{"key":"1834_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nrclinonc.2017.148","volume":"15","author":"SS Neelapu","year":"2018","unstructured":"Neelapu, S. S. et al. Chimeric antigen receptor T-cell therapy\u2014assessment and management of toxicities. Nat. Rev. Clin. Oncol. 15, 47\u201362 (2018).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1834_CR3","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nrclinonc.2017.43","volume":"14","author":"JJ Luke","year":"2017","unstructured":"Luke, J. J., Flaherty, K. T., Ribas, A. & Long, G. V. Targeted agents and immunotherapies: optimizing outcomes in melanoma. Nat. Rev. Clin. Oncol. 14, 463\u2013482 (2017).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1834_CR4","doi-asserted-by":"publisher","first-page":"4099","DOI":"10.1182\/blood-2010-04-281931","volume":"116","author":"JN Kochenderfer","year":"2010","unstructured":"Kochenderfer, J. N. et al. Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19. Blood 116, 4099\u20134102 (2010).","journal-title":"Blood"},{"key":"1834_CR5","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1056\/NEJMra1608969","volume":"377","author":"E Israel","year":"2017","unstructured":"Israel, E. & Reddel, H. K. Severe and difficult-to-treat asthma in adults. N. Engl. J. Med. 377, 965\u2013976 (2017).","journal-title":"N. Engl. J. Med."},{"key":"1834_CR6","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/S0140-6736(17)33311-1","volume":"391","author":"A Papi","year":"2018","unstructured":"Papi, A., Brightling, C., Pedersen, S. E. & Reddel, H. K. Asthma. Lancet 391, 783\u2013800 (2018).","journal-title":"Lancet"},{"key":"1834_CR7","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1016\/j.cell.2021.04.019","volume":"184","author":"H Hammad","year":"2021","unstructured":"Hammad, H. & Lambrecht, B. N. The basic immunology of asthma. Cell 184, 2521\u20132522 (2021).","journal-title":"Cell"},{"key":"1834_CR8","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1056\/NEJMra2032506","volume":"386","author":"GG Brusselle","year":"2022","unstructured":"Brusselle, G. G. & Koppelman, G. H. Biologic therapies for severe asthma. N. Engl. J. Med. 386, 157\u2013171 (2022).","journal-title":"N. Engl. J. Med."},{"key":"1834_CR9","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.coi.2020.10.004","volume":"66","author":"AP Hearn","year":"2020","unstructured":"Hearn, A. P., Kent, B. D. & Jackson, D. J. Biologic treatment options for severe asthma. Curr. Opin. Immunol. 66, 151\u2013160 (2020).","journal-title":"Curr. Opin. Immunol."},{"key":"1834_CR10","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1146\/annurev-immunol-093019-125918","volume":"39","author":"EA Jacobsen","year":"2021","unstructured":"Jacobsen, E. A. et al. Eosinophil knockout humans: uncovering the role of eosinophils through eosinophil-directed biological therapies. Annu. Rev. Immunol. 39, 719\u2013757 (2021).","journal-title":"Annu. Rev. Immunol."},{"key":"1834_CR11","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1016\/S0140-6736(16)31324-1","volume":"388","author":"ER Bleecker","year":"2016","unstructured":"Bleecker, E. R. et al. Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting beta(2)-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial. Lancet 388, 2115\u20132127 (2016).","journal-title":"Lancet"},{"key":"1834_CR12","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1016\/S0140-6736(16)31322-8","volume":"388","author":"JM FitzGerald","year":"2016","unstructured":"FitzGerald, J. M. et al. Benralizumab, an anti-interleukin-5 receptor alpha monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet 388, 2128\u20132141 (2016).","journal-title":"Lancet"},{"key":"1834_CR13","doi-asserted-by":"publisher","first-page":"e20232368","DOI":"10.1084\/jem.20232368","volume":"221","author":"L Wang","year":"2024","unstructured":"Wang, L. et al. Induction of immortal-like and functional CAR T cells by defined factors. J. Exp. Med. 221, e20232368 (2024).","journal-title":"J. Exp. Med."},{"key":"1834_CR14","doi-asserted-by":"publisher","first-page":"3395","DOI":"10.1002\/j.1460-2075.1995.tb07345.x","volume":"14","author":"S Cornelis","year":"1995","unstructured":"Cornelis, S. et al. Detailed analysis of the IL-5-IL-5R alpha interaction: characterization of crucial residues on the ligand and the receptor. EMBO J. 14, 3395\u20133402 (1995).","journal-title":"EMBO J."},{"key":"1834_CR15","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1126\/science.1076514","volume":"298","author":"ME Dudley","year":"2002","unstructured":"Dudley, M. E. et al. Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science 298, 850\u2013854 (2002).","journal-title":"Science"},{"key":"1834_CR16","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1016\/j.ymthe.2021.02.024","volume":"29","author":"JP Murad","year":"2021","unstructured":"Murad, J. P. et al. Pre-conditioning modifies the TME to enhance solid tumor CAR T cell efficacy and endogenous protective immunity. Mol. Ther. 29, 2335\u20132349 (2021).","journal-title":"Mol. Ther."},{"key":"1834_CR17","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41586-020-2403-9","volume":"583","author":"C Amor","year":"2020","unstructured":"Amor, C. et al. Senolytic CAR T cells reverse senescence-associated pathologies. Nature 583, 127\u2013132 (2020).","journal-title":"Nature"},{"key":"1834_CR18","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1038\/s41591-022-02017-5","volume":"28","author":"A Mackensen","year":"2022","unstructured":"Mackensen, A. et al. Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus. Nat. Med. 28, 2124\u20132132 (2022).","journal-title":"Nat. Med."},{"key":"1834_CR19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nri3341","volume":"13","author":"HF Rosenberg","year":"2013","unstructured":"Rosenberg, H. F., Dyer, K. D. & Foster, P. S. Eosinophils: changing perspectives in health and disease. Nat. Rev. Immunol. 13, 9\u201322 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"1834_CR20","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1016\/S0140-6736(07)61600-6","volume":"370","author":"S Wenzel","year":"2007","unstructured":"Wenzel, S., Wilbraham, D., Fuller, R., Getz, E. B. & Longphre, M. Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies. Lancet 370, 1422\u20131431 (2007).","journal-title":"Lancet"},{"key":"1834_CR21","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1074\/jbc.272.3.1480","volume":"272","author":"SM Grunewald","year":"1997","unstructured":"Grunewald, S. M. et al. A murine interleukin-4 antagonistic mutant protein completely inhibits interleukin-4-induced cell proliferation, differentiation, and signal transduction. J. Biol. Chem. 272, 1480\u20131483 (1997).","journal-title":"J. Biol. Chem."},{"key":"1834_CR22","doi-asserted-by":"publisher","first-page":"4004","DOI":"10.4049\/jimmunol.160.8.4004","volume":"160","author":"SM Grunewald","year":"1998","unstructured":"Grunewald, S. M. et al. Antagonistic IL-4 mutant prevents type I allergy in the mouse: Inhibition of the IL-4\/IL-13 receptor system completely abrogates humoral immune response to allergen and development of allergic symptoms in vivo. J. Immunol. 160, 4004\u20134009 (1998).","journal-title":"J. Immunol."},{"key":"1834_CR23","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.imlet.2009.03.008","volume":"123","author":"T Kouro","year":"2009","unstructured":"Kouro, T., Ikutani, M., Kariyone, A. & Takatsu, K. Expression of IL-5R\u03b1 on B-1 cell progenitors in mouse fetal liver and involvement of Bruton\u2019s tyrosine kinase in their development. Immunol. Lett. 123, 169\u2013178 (2009).","journal-title":"Immunol. Lett."},{"key":"1834_CR24","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1084\/jem.179.2.703","volume":"179","author":"S Dubucquoi","year":"1994","unstructured":"Dubucquoi, S. et al. Interleukin 5 synthesis by eosinophils: association with granules and immunoglobulin-dependent secretion. J. Exp. Med. 179, 703\u2013708 (1994).","journal-title":"J. Exp. Med."},{"key":"1834_CR25","doi-asserted-by":"publisher","first-page":"570","DOI":"10.3389\/fimmu.2014.00570","volume":"5","author":"F Davoine","year":"2014","unstructured":"Davoine, F. & Lacy, P. Eosinophil cytokines, chemokines, and growth factors: emerging roles in immunity. Front Immunol. 5, 570 (2014).","journal-title":"Front Immunol."},{"key":"1834_CR26","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.4049\/jimmunol.1700257","volume":"200","author":"DL Turner","year":"2018","unstructured":"Turner, D. L. et al. Biased generation and in situ activation of lung tissue-resident memory CD4 T cells in the pathogenesis of allergic asthma. J. Immunol. 200, 1561\u20131569 (2018).","journal-title":"J. Immunol."},{"key":"1834_CR27","doi-asserted-by":"publisher","first-page":"eabg9296","DOI":"10.1126\/sciimmunol.abg9296","volume":"7","author":"BJ Ulrich","year":"2022","unstructured":"Ulrich, B. J. et al. Allergic airway recall responses require IL-9 from resident memory CD4+ T cells. Sci. Immunol. 7, eabg9296 (2022).","journal-title":"Sci. Immunol."},{"key":"1834_CR28","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1146\/annurev-immunol-041015-055318","volume":"37","author":"LM McLane","year":"2019","unstructured":"McLane, L. M., Abdel-Hakeem, M. S. & Wherry, E. J. CD8 T cell exhaustion during chronic viral infection and cancer. Annu. Rev. Immunol. 37, 457\u2013495 (2019).","journal-title":"Annu. Rev. Immunol."},{"key":"1834_CR29","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/nature07924","volume":"458","author":"K Matsushita","year":"2009","unstructured":"Matsushita, K. et al. Zc3h12a is an RNase essential for controlling immune responses by regulating mRNA decay. Nature 458, 1185\u20131190 (2009).","journal-title":"Nature"},{"key":"1834_CR30","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1084\/jem.20182376","volume":"216","author":"JA Kotov","year":"2019","unstructured":"Kotov, J. A. et al. BCL6 corepressor contributes to Th17 cell formation by inhibiting Th17 fate suppressors. J. Exp. Med. 216, 1450\u20131464 (2019).","journal-title":"J. Exp. Med."},{"key":"1834_CR31","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1146\/annurev-immunol-101220-023458","volume":"40","author":"T Kishimoto","year":"2022","unstructured":"Kishimoto, T. & Kang, S. IL-6 revisited: from rheumatoid arthritis to CAR T cell therapy and COVID-19. Annu. Rev. Immunol. 40, 323\u2013348 (2022).","journal-title":"Annu. Rev. Immunol."},{"key":"1834_CR32","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/nprot.2014.005","volume":"9","author":"KG Anderson","year":"2014","unstructured":"Anderson, K. G. et al. Intravascular staining for discrimination of vascular and tissue leukocytes. Nat. Protoc. 9, 209\u2013222 (2014).","journal-title":"Nat. Protoc."},{"key":"1834_CR33","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nri.2015.3","volume":"16","author":"SN Mueller","year":"2016","unstructured":"Mueller, S. N. & Mackay, L. K. Tissue-resident memory T cells: local specialists in immune defence. Nat. Rev. Immunol. 16, 79\u201389 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"1834_CR34","doi-asserted-by":"publisher","first-page":"3548","DOI":"10.4049\/jimmunol.1302241","volume":"192","author":"TW Wong","year":"2014","unstructured":"Wong, T. W., Doyle, A. D., Lee, J. J. & Jelinek, D. F. Eosinophils regulate peripheral B cell numbers in both mice and humans. J. Immunol. 192, 3548\u20133558 (2014).","journal-title":"J. Immunol."},{"key":"1834_CR35","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/cei.12695","volume":"183","author":"C Berek","year":"2016","unstructured":"Berek, C. Eosinophils: important players in humoral immunity. Clin. Exp. Immunol. 183, 57\u201364 (2016).","journal-title":"Clin. Exp. Immunol."},{"key":"1834_CR36","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.cyto.2004.08.007","volume":"28","author":"G Yang","year":"2004","unstructured":"Yang, G. et al. Anti-IL-13 monoclonal antibody inhibits airway hyperresponsiveness, inflammation and airway remodeling. Cytokine 28, 224\u2013232 (2004).","journal-title":"Cytokine"},{"key":"1834_CR37","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1146\/annurev-pathol-042220-015902","volume":"18","author":"H Aegerter","year":"2023","unstructured":"Aegerter, H. & Lambrecht, B. N. The pathology of asthma: what is obstructing our view?. Annu. Rev. Pathol. 18, 387\u2013409 (2023).","journal-title":"Annu. Rev. Pathol."},{"key":"1834_CR38","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41577-020-0301-x","volume":"20","author":"WC Gause","year":"2020","unstructured":"Gause, W. C., Rothlin, C. & Loke, P. Heterogeneity in the initiation, development and function of type 2 immunity. Nat. Rev. Immunol. 20, 603\u2013614 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"1834_CR39","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/s41421-022-00433-y","volume":"8","author":"S Chen","year":"2022","unstructured":"Chen, S. et al. Treatment of allergic eosinophilic asthma through engineered IL-5-anchored chimeric antigen receptor T cells. Cell Discov. 8, 80 (2022).","journal-title":"Cell Discov."},{"key":"1834_CR40","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1093\/intimm\/5.9.1183","volume":"5","author":"Y Hitoshi","year":"1993","unstructured":"Hitoshi, Y. et al. IL-5 receptor positive B cells, but not eosinophils, are functionally and numerically influenced in mice carrying the X-linked immune defect. Int. Immunol. 5, 1183\u20131190 (1993).","journal-title":"Int. Immunol."},{"key":"1834_CR41","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1111\/all.14221","volume":"75","author":"I Agache","year":"2020","unstructured":"Agache, I. et al. Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma. Allergy 75, 1023\u20131042 (2020).","journal-title":"Allergy"},{"key":"1834_CR42","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.it.2022.12.003","volume":"44","author":"X Xing","year":"2023","unstructured":"Xing, X. & Hu, X. Risk factors of cytokine release syndrome: stress, catecholamines, and beyond. Trends Immunol. 44, 93\u2013100 (2023).","journal-title":"Trends Immunol."},{"key":"1834_CR43","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/nbt.4195","volume":"36","author":"S Rafiq","year":"2018","unstructured":"Rafiq, S. et al. Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo. Nat. Biotechnol. 36, 847\u2013856 (2018).","journal-title":"Nat. Biotechnol."},{"key":"1834_CR44","doi-asserted-by":"publisher","first-page":"eaba1624","DOI":"10.1126\/science.aba1624","volume":"378","author":"GM Allen","year":"2022","unstructured":"Allen, G. M. et al. Synthetic cytokine circuits that drive T cells into immune-excluded tumors. Science 378, eaba1624 (2022).","journal-title":"Science"},{"key":"1834_CR45","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/cpmo.4","volume":"6","author":"N Debeuf","year":"2016","unstructured":"Debeuf, N., Haspeslagh, E., van Helden, M., Hammad, H. & Lambrecht, B. N. Mouse models of asthma. Curr. Protoc. Mouse Biol. 6, 169\u2013184 (2016).","journal-title":"Curr. Protoc. Mouse Biol."},{"key":"1834_CR46","doi-asserted-by":"publisher","first-page":"4004","DOI":"10.4049\/jimmunol.160.8.4004","volume":"160","author":"SM Grunewald","year":"1998","unstructured":"Grunewald, S. M. et al. An antagonistic IL-4 mutant prevents type I allergy in the mouse: inhibition of the IL-4\/IL-13 receptor system completely abrogates humoral immune response to allergen and development of allergic symptoms in vivo. J. Immunol. 160, 4004\u20134009 (1998).","journal-title":"J. Immunol."},{"key":"1834_CR47","doi-asserted-by":"publisher","first-page":"5792","DOI":"10.4049\/jimmunol.166.9.5792","volume":"166","author":"A Tomkinson","year":"2001","unstructured":"Tomkinson, A. et al. A murine IL-4 receptor antagonist that inhibits IL-4- and IL-13-induced responses prevents antigen-induced airway eosinophilia and airway hyperresponsiveness. J. Immunol. 166, 5792\u20135800 (2001).","journal-title":"J. Immunol."},{"key":"1834_CR48","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1084\/jem.20030298","volume":"198","author":"S Myou","year":"2003","unstructured":"Myou, S. et al. Blockade of inflammation and airway hyperresponsiveness in immune-sensitized mice by dominant-negative phosphoinositide 3-kinase-TAT. J. Exp. Med. 198, 1573\u20131582 (2003).","journal-title":"J. Exp. Med."},{"key":"1834_CR49","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1007\/PL00000243","volume":"50","author":"H Tanaka","year":"2001","unstructured":"Tanaka, H. et al. The effect of allergen-induced airway inflammation on airway remodeling in a murine model of allergic asthma. Inflamm. Res 50, 616\u2013624 (2001).","journal-title":"Inflamm. Res"}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41590-024-01834-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-024-01834-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-024-01834-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T14:10:49Z","timestamp":1717596649000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41590-024-01834-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,27]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["1834"],"URL":"https:\/\/doi.org\/10.1038\/s41590-024-01834-9","relation":{},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,27]]},"assertion":[{"value":"16 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A patent application based on the findings described in this study has been filed by Tsinghua University with M.P. listed as an inventor. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}